Modern Cannabis Is No Harmless Weed: Confronting the UK’s Policy Contradiction

Young man smoking weed. The picture is in the public domain.
Young man smoking weed. The picture is in the public domain.

For decades, cannabis has occupied a curious place in British law and culture: criminalized by statute yet tolerated in practice; decried as a gateway drug yet celebrated for its medical uses; widely perceived as benign by many, even as leading psychiatric bodies raise alarm bells. Today’s cannabis landscape—with ultra‑high‑potency “skunk” available on every urban corner—bears little resemblance to the low‑THC herbal material of the 1970s. Yet the UK’s patchwork enforcement and public messaging remain stuck in the past, failing to reckon with a mounting body of evidence linking modern cannabis use to serious and, in some cases, irreversible harms.

Most pedestrians in the UK have smelt the strong odour of cannabis smoke when walking in a park for instance. It can be easy detected from 50 or more yards away downwind! It is accepted as normal but it is potentially dangerous despite the known health benefits under controlled conditions. Yes, it can be medicinal but the dangers need to be highlighted.

P.S. There is also the issue of selling and smoking cannabis fostering low-level crime which can lead to more serious crime. Cannabis promotes crime is the argument. The police’s inaction is counter to their purpose. They are encouraging crime in effect. Of course the police don’t see it like that but they should. Or they’d blame a lack of sufficient funding. Their usual excuse for laziness.

“It has completely ruined his life, and as parents we have had to suffer the bereavement of losing our son. Fundamentally, it has damaged his brain for good. Young people need to know smoking cannabis is playing Russian roulette with brain damage.”- Terry the father of Steven now 42 whose life was ruined by skunk a potent synthetic version of cannabis.


From Law on the Books to De Facto Decriminalization

Under the Misuse of Drugs Act 1971, cannabis is classified as a Class B substance, punishable by up to five years’ imprisonment for possession and 14 years for supply or production. In practice, however, police forces across England and Wales have quietly shifted to “harm‑reduction” approaches: warnings, community resolutions, or £45 online awareness courses replace fines and prosecutions for most first‑time or low‑level offences. Thames Valley Police, for example, dealt with 71% of cannabis possession cases via community resolution in 2024–25—up from 8% a decade earlier—while only 16% of such incidents nationally now lead to charges.

Personally I have reported cannabis use to the local police and they have in effect told me to get lost! The police just don’t enforce the law. Oh, that applies to many other crimes as it happens like massive car theft and mass shoplifting to cite just two examples – there are many others.

This “don’t ask, don’t enforce” policy may spare thousands from criminal records, but it also sends a confusing message: cannabis remains illegal—yet almost nobody is punished. Without clear, consistent enforcement or public health campaigns akin to those for alcohol and tobacco, the public is left to assume that cannabis poses few real risks.


The Science Is In: Key Harms of High‑Potency, Early, and Frequent Use

1. Psychosis and Schizophrenia

A landmark 2019 Lancet Psychiatry case‑control study of 2,138 participants across 11 international urban centres found that daily users of high‑THC cannabis (>10% THC) were five times more likely to experience a first episode of psychosis than non‑users. South London—the study’s highest‑incidence site—recorded 45.7 new cases of psychosis per 100,000 people each year, the highest rate in Europe. Researchers estimated that roughly 30% of those cases could be prevented if access to high‑potency cannabis were curtailed.

The Royal College of Psychiatrists has echoed this concern: “The younger you are when you start using cannabis, the greater the risk of developing psychosis,” a statement that reflects both the Lancet findings and decades of clinical observation.

2. Adolescent Brain Development

The teenage brain remains malleable well into the mid‑20s. Introducing high doses of THC during adolescence disrupts critical processes of synaptic pruning and white‑matter maturation—pathways governing executive function, attention, and emotional regulation. Longitudinal research, including New Zealand’s renowned Dunedin study, documents an eight‑point average IQ drop among persistent teen cannabis users, even after controlling for other factors. Early onset (under age 16) has been consistently linked to poorer academic outcomes, higher rates of school dropout, and increased risk of anxiety, depression, and substance dependence.

3. Dependence and Cognitive Impairment

Cannabis often masquerades as a low-addiction substance, yet 9–10% of all users develop Cannabis Use Disorder (CUD)—a figure that rises to 1 in 6 for those who begin in adolescence and daily users. Chronic, heavy use has been associated with impairments in memory, decision‑making, and motivation, sometimes persisting for months after cessation. With modern street cannabis routinely testing at 15–25% THC, compared to 2–5% in the 1980s, today’s users face a potency‑driven dependency risk unheard of by previous generations.

4. Pregnancy, Neonatal, and Long‑Term Child Outcomes

THC crosses both the placental barrier and is secreted in breast milk. A 2025 meta‑analysis in JAMA Pediatrics—covering more than 21 million births—found cannabis use during pregnancy increases the risk of premature birth by 52%, low birth weight by 75%, and infant mortality by 29%. Growing evidence also links prenatal exposure to later cognitive and behavioral issues in children, including attention‑deficit disorders, memory deficits, and social‑emotional dysregulation.

5. Aging, Cognition, and Dementia

Emerging data from U.S. veteran cohorts (average age 73) indicate that older cannabis users are 1.5 times more likely to be diagnosed with dementia within five years than non‑users, even after adjusting for comorbidities. While causality remains unproven, these observational signals suggest that long‑term cannabis exposure—especially via inhalation—may accelerate age‑related cognitive decline.

Benjamin Han, a geriatrician and addiction medicine specialist at the University of California-San Diego said:

“”The benefits are still unclear but we’re seeing more evidence of potential harms.”

Also:

“One national survey found that a growing proportion of American adults — 44% in 2021 — erroneously thought it safer to smoke cannabis daily than cigarettes. The authors of the study, in JAMA Network Open, noted that ‘these views do not reflect the existing science on cannabis and tobacco smoke.'” – National Medical Life Sciences.


The UK’s Policy Paradox

Despite this robust evidence, the UK government and police remain reluctant to either enforce the law as written or to upgrade public health messaging. The result is a policy vacuum in which:

  1. Potency Is Unregulated. No labeling requirements; consumers—often young—cannot make informed choices.
  2. Youth Prevention Is Weak. Absent school curricula, public awareness campaigns, or clear guidance, teens are left to learn about cannabis’s downsides by trial, error, and urban myth.
  3. Mixed Signals Abound. A law that criminalizes, policing that tolerates, and a public discourse that oscillates between “it’s harmless” and “it’s medicine.”

This policy limbo serves neither public health nor social justice. A clear, evidence‑based approach would acknowledge cannabis’s real harms—particularly from high‑potency products—and adopt harm‑reduction strategies grounded in regulation, education, and targeted youth prevention.

Sidebar: In the US cannabis is legal in many states but is its use not only damaging brains but also society? Some thoughts:

While cannabis legalization in many U.S. states has brought economic benefits and criminal justice reform, concerns remain about the broader societal harms that cannabis use and its normalization might cause. One key issue is the potential rise in impaired driving incidents. Cannabis affects reaction time, coordination, and judgment, increasing the risk of car accidents. Unlike alcohol, reliable roadside testing for cannabis impairment remains limited, complicating law enforcement efforts and public safety.

Another societal concern is the impact on youth. Legalization often leads to increased availability and reduced perceived risk among teenagers, who may be more likely to experiment with cannabis. Early and frequent use during adolescence is linked to poorer educational outcomes, reduced motivation, and higher dropout rates. This can perpetuate cycles of disadvantage, especially in communities where resources for prevention and treatment are lacking.

Cannabis use may also contribute to workplace challenges. Impairment on the job can reduce productivity, increase accidents, and complicate employer liability. In safety-sensitive industries, cannabis use poses real risks that current drug testing policies struggle to manage fairly and effectively.

Moreover, the normalization and commercialization of cannabis can lead to increased overall consumption. This may escalate public health costs associated with cannabis-related mental health issues, including anxiety, depression, and in some cases, psychosis. Vulnerable populations may suffer disproportionately, deepening existing social inequities.

Finally, some critics argue that cannabis legalization can undermine social cohesion by promoting substance use as a normative behavior, potentially weakening community standards around drug use and its consequences.

In conclusion, while cannabis legalization offers some clear benefits, it also presents complex societal challenges. Addressing impaired driving, protecting youth, managing workplace safety, and mitigating public health costs will be essential to minimize cannabis’s potential damage to American society.


Toward Coherent, Health‑Focused Reform

1. Regulate THC Content.
Set a maximum allowable THC concentration for legal, regulated products. Above‑limit sales would remain illegal, shrinking the black market for ultra‑strong material.

2. Mandatory Labeling and Testing.
Require licensed producers to test and label cannabis for THC and CBD content—alongside warnings about mental health risks, dependence potential, and pregnancy advisories.

3. Public Health Campaigns.
Launch a national “Modern Cannabis ≠ Harmless” campaign, akin to anti‑tobacco smears or drink‑driving adverts, emphasizing risks to adolescent brains, mental health, and maternal‑child outcomes.

4. Youth‑Focused Education.
Integrate cannabis‑specific modules into secondary school health curricula—covering neurodevelopment, psychosis linkage, and dependency signs—delivered independently of law enforcement rhetoric.

5. Enforcement Priorities.
Target strict penalties at unlicensed production and supply of high‑potency cannabis (smuggling, synths, concentrates), while maintaining diversion and education measures for simple possession.

6. Research and Surveillance.
Fund longitudinal cohort studies in the UK to monitor cognitive, psychiatric, and physical health outcomes of diverse user groups—informing future policy adjustments.


A Call to Arms

It is time for MPs, public health officials, and police leaders to end the schizophrenic approach to cannabis. The scientific consensus is clear: modern, high‑potency cannabis carries significant mental health risks—risks that are magnified in young users and hidden from a public lulled by myths of harmless greenery.

We can neither clamp down so hard as to criminalize tens of thousands of otherwise law‑abiding citizens, nor drift along, content to be surprised by skyrocketing rates of psychosis, dependency, or cognitive decline. Instead, the UK must stride toward sensible, health‑first regulation—controlling potency, educating youth, and protecting vulnerable populations.

Only a coherent, evidence‑based policy will reconcile the law on the books with the realities on our streets, and only then will we truly safeguard public health in an era of rapidly evolving cannabis culture. Let us abandon wishful thinking and acknowledge: cannabis today is far from harmless—and it’s high time our policies caught up.

More: cannabis

Sidebar: Exploring the Link Between Cannabis Use, Mental Health, and Employment in UK Youth

Background:
The UK faces a growing crisis of mental health issues among young people aged roughly 18–30 who are physically fit to work but remain unemployed or underemployed, often relying on welfare benefits. This raises questions about underlying causes, including substance use.

Cannabis and Mental Health:

  • Research internationally shows cannabis use, especially frequent or heavy use starting in adolescence, is associated with increased risk of mental health problems such as anxiety, depression, and psychosis.
  • Mental health challenges linked to cannabis can reduce cognitive functioning, motivation, and emotional stability, which are vital for maintaining employment.

Cannabis Use and Employment:

  • Studies suggest cannabis users are less likely to complete education and have lower employment rates compared to non-users.
  • Cognitive impairment or motivational issues (“amotivational syndrome”) possibly linked to cannabis can affect job performance or job-seeking behavior.
  • In the UK context, data on cannabis’s direct impact on employment status is sparse but anecdotal reports and smaller studies suggest it may be a contributing factor.

Complex, Multifactorial Nature:

  • Mental health issues and unemployment are influenced by socioeconomic status, education, family environment, trauma, and broader systemic factors.
  • Cannabis use may interact with these factors, exacerbating problems or acting as a coping mechanism.

Potential Research Directions:

  1. Cross-sectional Surveys: Collect data on cannabis use, mental health symptoms, and employment status in UK youth to identify correlations.
  2. Longitudinal Studies: Follow cohorts over time to track cannabis use initiation, mental health trajectory, and employment outcomes.
  3. Qualitative Research: Interview young people to understand their experiences of cannabis use, mental health challenges, and barriers to work.
  4. Policy Analysis: Examine the impact of drug policies and welfare benefits on young people’s cannabis use and employment.

Conclusion:
While causality is difficult to establish, existing evidence justifies further research into how cannabis use may contribute to the mental health and employment crisis among young UK adults. Understanding these links can inform targeted interventions, prevention programs, and support services to help young people thrive.

Sidebar: Work. I have seen young tradesmen working early in the morning puffing on cannabis. It seems that they use cannabis throughout the day while working! It helps get them through the boring day.

More: Using cannabis during the workday, especially in physically demanding or repetitive jobs like trades, can indeed be a coping strategy for some workers trying to manage boredom, stress, or physical discomfort. However, this practice raises several concerns:

  • Safety risks: Cannabis impairs coordination, reaction time, and judgment, which are critical for operating machinery, handling tools, or working at heights. This increases the risk of workplace accidents and injuries—not only for the user but for coworkers as well.
  • Productivity and quality: While cannabis might help alleviate boredom or monotony, it can also reduce focus, motivation, and precision. Over time, this might lead to lower productivity or work quality.
  • Health implications: Using cannabis repeatedly throughout the day may increase tolerance and dependence, and may worsen mental health symptoms like anxiety or cognitive fog, especially if used to self-medicate stress or dissatisfaction.
  • Cultural normalization: When cannabis use becomes part of the workplace culture, it may discourage people who don’t use from speaking up about safety concerns or seeking help.

This phenomenon points to wider issues around job satisfaction, workplace stress, and mental health support for workers in blue-collar roles. It’s important to understand why workers turn to cannabis during their shifts—is it boredom, chronic pain, anxiety, or something else? Addressing those root causes could reduce reliance on cannabis while improving safety and wellbeing.

Sidebar: cat caregiving is negatively impacted by cannabis use both directly and indirectly.

More: Legalizing Cannabis Leads to More Pet Owners Giving it to Their Cats and Dogs

More: Decriminalizing drugs is harmful to both pets and people

follow it link and logo
Note: Some older videos on this page were hosted on Vimeo. That account has now been retired, so a few video blocks may appear blank. Thanks for understanding — there’s still plenty of cat content to enjoy!